Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment

Published:2018-10 Issue:7 Volume:40 Page:541-547
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Vedi Aditi,Mitchell Richard,Shanmuganathan Sunita,Oswald Cecilia,Marshall Glenn M.,Trahair Toby,Sivarajasingam Siva,Ziegler David S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia;Webb;Blood,2001

2. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials;Creutzig;Leukemia,2005

3. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98;Creutzig;J Clin Oncol,2006

4. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down’s syndrome: results of NOPHO-AML trials;Lie;Br J Haematol,2003

5. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. MRC Childhood Leukaemia Working Party;Stevens;Br J Haematol,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetic characteristics of and prognosis for acute myeloid leukemia in 107 children;Asian Biomedicine;2021-04-01

2. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells;Haematologica;2020-09-28

3. Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition;Oncohematology;2020-07-16

4. Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study;Molecules;2019-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3